Functional enrichment analyses showed that several cancer progression-related terms and pathways were enriched, such as MYC/E2F targets, ECM-receptor interaction, and epithelial mesenchymal transition, consistent with the poorer prognosis of the high-risk group and suggesting that patients in the high-risk group may be at higher degree of cancer-related pathways activation. This evidence concerns the gene MYC and cancer.